Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for open house pharmaceutical discount agreements for Ivermectin (ATC D11AX22) by AOK Bayern in Munich, Germany. The earliest contract start date is January 1, 2027, and all contracts will end on December 31, 2028. Contracts can be concluded anytime during this period, but no later than November 3, 2028.
Scope Of Work: AOK Bayern seeks to establish non-exclusive discount agreements for Ivermectin with interested pharmaceutical companies. The agreements will be identical and non-negotiable, following the open-house model. Contracts can be initiated anytime until the deadline, with a one-month termination notice required. The agreements will be void if a nationwide or state-specific discount contract for the same active ingredient is established. Interested companies must submit a completed and signed declaration of reliability along with the contract and relevant documentation.
Qualification Criterion: Eligible bidders must be pharmaceutical companies that submit a completed and signed declaration of reliability. The contract must be signed by an authorized representative, with proof of authority required. Submissions can be made either in handwritten form or electronically with a qualified electronic signature. Handwritten documents must be sent in duplicate to the specified address in Munich. Electronic submissions should be made via the designated procurement portal. All documents are to be treated confidentially.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |